Kim, E., Hurtz, C., Koehrer, S., Wang, Z., Balasubramanian, S., Chang, B. Y., . . . Burger, J. A. (2017). Ibrutinib inhibits pre-BCR(+) B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK. Blood.
Citación estilo ChicagoKim, Ekaterina, Christian Hurtz, Stefan Koehrer, Zhiqiang Wang, Sriram Balasubramanian, Betty Y. Chang, Markus Müschen, R. Eric Davis, and Jan A. Burger. "Ibrutinib Inhibits Pre-BCR(+) B-cell Acute Lymphoblastic Leukemia Progression By Targeting BTK and BLK." Blood 2017.
Cita MLAKim, Ekaterina, et al. "Ibrutinib Inhibits Pre-BCR(+) B-cell Acute Lymphoblastic Leukemia Progression By Targeting BTK and BLK." Blood 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.